Skip to main content
SUPN logo
SUPN
(NASDAQ)
Supernus Pharmaceuticals, Inc.
$45.85-- (--)
Loading... - Market loading

Supernus Pharmaceuticals (SUPN) Stock Price & Financial Analysis

Supernus Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$48.51 - $49.82
52-Week High$59.68
52-Week Low$41.78
Open$49.50
Volume797.21K
Average Volume (3M)914.03K
Market Cap2.80B
Shares Outstanding57.65M
Price to Sales (P/S)3.58
Price to Book (P/B)2.58
EV/EBITDA58.72
Revenue (TTM)776.83M
Net Income (TTM)-29.02M
Free Cash Flow (TTM)82.25M
EPS (TTM)$-0.51
Profit Margin-3.74%
Operating Margin-5.37%
Return on Equity (ROE)-2.69%
Debt to Equity0.04
50-Day MA$46.48
200-Day MA$48.79
52-Week Change13.07%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Supernus Pharmaceuticals

What is the current stock price for SUPN?

As of the latest trading session, SUPN stock trades at $48.54. The 52-week range is $41.78–$59.68, with a day range of $48.51–$49.82.

What is the P/E ratio for SUPN?

The P/E ratio (Price-to-Earnings) for SUPN is shown in the Key Statistics section. This valuation metric helps compare Supernus Pharmaceuticals, Inc. to industry peers.

Does SUPN pay dividends?

Supernus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SUPN?

Based on 4 analysts, the consensus for SUPN is Buy.

What is the market cap of SUPN?

Supernus Pharmaceuticals's market capitalization is $2.80B, classifying it as a mid-cap company. Supernus Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.